Accretion Nutraveda

| Annual Financials | 2023 | 2024 | 2025 | TTM |
Revenue  | 3 | 5 | 16 | 0 |
| Expenses | 2 | 4 | 12 | 0 |
EBITDA  | 1 | 1 | 4 | 0 |
| Operating Profit % | 21 % | 24 % | 23 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 |
Profit Before Tax  | 0 | 1 | 3 | 0 |
| Tax | 0 | 0 | 1 | 0 |
| Net Profit | 0 | 1 | 3 | 0 |
| EPS in ₹ | 7.79 | 22.83 | 71.91 | 0.00 |
Above figures are in Rs. Crores | Balance Sheet | 2023 | 2024 | 2025 |
Total Assets  | 4 | 5 | 11 |
| Fixed Assets | 2 | 1 | 2 |
| Current Assets | 3 | 3 | 9 |
| Capital Work in Progress | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Other Assets | 3 | 3 | 9 |
Total Liabilities  | 4 | 5 | 11 |
| Current Liabilities | 2 | 3 | 4 |
| Non Current Liabilities | 1 | 1 | 2 |
Total Equity  | 0 | 1 | 5 |
| Reserve & Surplus | -0 | 1 | 5 |
| Share Capital | 0 | 0 | 1 |
Above figures are in Rs. Crores | Cash Flow | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | -0 |
| Investing Activities | 0 | -0 | -1 |
| Operating Activities | 1 | 0 | -2 |
| Financing Activities | -1 | 0 | 3 |
Above figures are in Rs. Crores | % Holding | Sept 2025 | Feb 2026 |
| Promoter | 100.00 % | 73.48 % |
| FIIs | 0.00 % | 6.04 % |
| DIIs | 0.00 % | 6.51 % |
| Government | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 10.48 % |
| Others | 0.00 % | 3.49 % |
| No of Share Holders | 10 | 407 |
RSI(14)

Oversold
0.00
ATR(14)

Volatile
0.00
STOCH(9,6)

Oversold
0.00
STOCH RSI(14)

Oversold
0.00
MACD(12,26)

Bearish
0.00
ADX(14)

Weak Trend
0.00
UO(9)

Bullish
0.00
ROC(12)

Uptrend And Accelerating
0.73
WillR(14)

Overbought
0.00